AgTech BioTech Research

Origin Agritech announces GMO soybean development & commercialization collaboration

Origin Agritech Ltd., an agriculture technology company announced that the Company has entered into a collaboration agreement with Biotechnology Research Institute (BRI), a division of Chinese Academy of Agriculture Sciences (CAAS) to expand collaborations in GMO soybean research and commercialization. By using G2-epsps gene, BRI developed GMO glyphosate tolerance soybean, which received a bio-safety certificate on July 15, 2020.

The new collaboration agreement deepens Origin’s cooperation with BRI and mainly focuses on related research and commercialization of GMO soybean. BRI will focus on fundamental research and provide technical support to Origin on GMO soybean product development and global commercialization.

“We are very pleased to further deepen our collaboration with Origin. The new agreement will definitely promote GMO soybean research and commercialization which will increase soybean production and benefit Chinese farmers and consumers in China as well as other parts of the world.”

Dr. Li Xinhai, Director, Biotechnology Research Institute

In addition to glyphosate tolerance G2-epsps gene, which BRI developed and Origin has global exclusive commercial rights in corn, soybean, and other major crops, Origin and BRI will expand the collaboration to develop dicamba tolerance, drought tolerance, and salt-alkaline tolerance GMO soybean varieties by using three BRI newly developed and patented genes.

Over the years, Origin has been cooperating with BRI in developing various GM traits, including GMO phytase corn, glyphosate tolerance corn, and double stacked insect resistance and glyphosate tolerance corn.

About Origin Agritech Limited

Founded in 1997 and headquartered in the Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, Origin Agritech Limited (NASDAQ GS: SEED) is China’s leading agricultural biotechnology company. Origin Agritech is specialised in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. As the first Chinese seed company with an in-house biotech research center, Origin leads the development of Genetically Modified (GM) technology.

About Biotechnology Research Institute (BRI)

The Biotechnology Research Institute (BRI) of Chinese Academy of Agricultural Sciences (CAAS) was founded in 1986 and it is the only public, non-profit institution focusing on the frontiers of both basic and applied research of agro-biotechnology in China. The Key Laboratory of Agricultural Genomics, Ministry of Agriculture (MOA) and the Center for Biosafety Assessment of GMOs are affiliated to BRI-CAAS